CENTOGENE Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test
July 02, 2020 08:03 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 02, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress
June 15, 2020 06:30 ET
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 15, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENE Marks Rare Disease Day 2020 With a Global Line up of Events
February 29, 2020 00:00 ET
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 29, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical...
CentoMD® Update Reveals Continued Growth of Rare Hereditary Disease Knowledge Base
December 16, 2019 06:37 ET
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany, Dec. 16, 2019 (GLOBE NEWSWIRE) -- In an update released today by CENTOGENE (Nasdaq: CNTG) to CentoMD® - the Company’s data repository of epidemiologic,...
CENTOGENE Expands Executive Leadership Team
December 06, 2019 06:00 ET
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany, Dec. 06, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG) today announced the expansion of its executive leadership team with the appointment of Philip...
Centogene reporting its financial results for the three months and nine months ended September 30, 2019
December 05, 2019 06:28 ET
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 05, 2019 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENE to Announce Third Quarter 2019 Financial Results on 5th December 2019
December 02, 2019 03:00 ET
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 02, 2019 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENE Announces Temporary Leave of Absence of Holger Friedrich from the Supervisory Board
November 21, 2019 08:54 ET
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 21, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical...
CENTOGENE Signs New Collaboration with PTC Therapeutics for Global Diagnostic Testing Program
November 18, 2019 08:00 ET
|
Centogene AG
CAMBRIDGE, Ma. and ROSTOCK, Germany, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and...
CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.
November 13, 2019 03:23 ET
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 13, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical...